SESSION TITLE: Mechanisms of Lung Cancer
SESSION TYPE: Original Investigation Slide
PRESENTED ON: Saturday, April 16, 2016 at 02:15 PM - 03:45 PM
PURPOSE: The findings of EGFR mutations and the development of targeted therapies have significantly improved the overall survival of lung cancer patients. Still, the prognosis remains poor, so we need to know more about the genetic alterations in lung cancer. MicroRNAs are dysregulated in lung cancer, and microRNAs can regulate EGFR. So it is important to predict the candidate microRNAs that target mutated EGFR and to investigate the availability of these candidate microRNAs regulators in lung cancer.